Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab.
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to Cetuximab. Mol Cancer Ther. 2016 09; 15(9):2175-86.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Proliferation
Cetuximab
Disease Models, Animal
Drug Resistance, Neoplasm
ErbB Receptors
Female
Head and Neck Neoplasms
Humans
Male
Mice
Protein Kinase Inhibitors
Receptor, ErbB-2
Receptor, ErbB-3
Tumor Burden
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia